最近收录_第1108页_生物活性分子
生物活性分子最近更新
Bismuth sodium oxide
Tppp
SX
promyelocytic
Azure B (Standard)
PDD
PAR2 抗体 (YA2455)（PAR2 Antibody (YA2455)）
Lipid I
RU
BEBT 109
Lyn 抗体 (YA4957)（Lyn Antibody (YA4957)）
VDJ001
XNW
neutropenia
Cryptanoside A
Benoxacor
INVA 8001
PF 07247685
Isolicoflavonol
Gcdh
PNU 282987
anti
BAY
JTT
Bass hepcidin
SHR
A77 1726
Cy7.5 PEG
Bacterial transcription
HBV mutant
GSNO (Standard)
drug target
Sch13835
Kobe 0065
BuChE
ZK824859
ELN484228
Afm
VVD
BAFFR 抗体 (YA4437)（BAFFR Antibody (YA4437)）
MDL 899
Bacoside A
VU6036720
LY 127809
WAY 361789
URC102
MD 001
Psen1 Rat Pre
CD35 抗体 (YA1328)（CD35 Antibody (YA1328)）
Styrylpyrones
Fluorescent brightener 24
Alpk2
Gpat3
Thevefolic acid B
D
A Chemical Biology Toolbox Targeting the Intracellular Binding Site of CCR9 Fluorescent Ligands, New Drug Leads and PROTACs PMID 34936714
STOM Human Pre
FIBIN Human Pre
ECHDC1 Human Pre
H
Licoagroside D
Gumokimab
Omp
mouse spleen
LY
PGF2α THAM
ZK
SB 203186
(E)
Irx3 Mouse Pre
HBA1 Human Pre
α1a,α1b
FZD3 Human Pre
Ostm1
Mouse cyanogen bromide digested peptide
R 523062
LMF1 Human Pre
Arf5
bacterial volatile organic compound
Uba5
Goshonoside F1
EL
Citronellyl
VU0531245
Famotidine impurity7
Vilazodone Intermediate
GW 870086
3'
Design, synthesis, and biological evaluation of dithiocarbamate derivatives as SARS
Hexapeptide 3
BMS 195614
SHY 855
L 697661
Br
Dihydrodehydrodiconiferyl alcohol 28199
9
Divesiran
MRS
BLU 222
competitive antagonism
Cedelizumab
BI 3812
mCMY
Healthcare
ZK139834
BAY
Icariside F2
Potassiumtbutoxide
Methyl gerfelin
KY
16HBE cells
SB1
FPA 008
CL14377 (Standard)
PF
Anti
chemical indicator
AZD
Cefdaloxime
DLL4
BYM 338
neurotransmission
KOR agonist
ICI
EGFR TKI
DNDI
neutral protease
ATTO 488 biotin
BI1015550
HUHS 015
BRD
CAY
osinophils
AB 3217
ZY
NPY receptor
LOXO 338
Adynerigenin beta
covalent reversible
CGA 13586
Telomerase
HIV
MBX 1162
Saussureamine C
CGRP antagonist
IONIS
B
GRPR antagonist 2
SKPin C
AZ 3146
CK 869
LY
Nagrestipen
Fitusiran
Ro 5
BC
Barbinervic acid
Coumarin
Steviol
SQ
BAY
CD8 alpha 抗体(YA6867)（CD8 alpha Antibody(YA6867)）
Afovirsen
Cdh2
Deamino
drug
HMGB 1
9C
Benzil (Standard)
17
POPC membranes
SHS4121705
LZIC Human Pre
SKF
CX 04328
C24 (2'(S)
CASP2 Human Pre
4ʹ
Endothelial lipase inhibitor
type I enzyme
(S)
PROCR Human Pre
RNASEH2C Human Pre
AChE
Vt
KERA
CAY10789
VEGFR2
Ell
STK10
Bassiatin
6α
Tuvonralimab
H
DSPE
NUBPL Human Pre
ONO
PCNT Human Pre
Polyphosphoinositides produced by phosphatidylinositol 3
Structure
[(pF)Phe4]Nociceptin(1
Astrocyte
Synthesis and Incorporation of Unnatural Amino Acids To Probe and Optimize Protein Bioconjugations PMID 26287719
Antitumor agent
Tremella polysaccharide The molecular mechanisms of its drug action PMID 31030755
Further studies on ethyl 5
Rac
Seliciclib (CYC202, R
Pharmacological characterisation of [(pX)Phe4]nociceptin(1
Dihydrofluorescein diacetate is superior for detecting intracellular oxidants comparison with 2',7'
N
Nomifensine maleate 32795
tert
(
4
Pharmacological characterisation of [(pX)Phe4]nociceptin(1
Ethyl 5
AKAP8L Human Pre
indole
3
L
N
Pentanoyl
ACH 000143
Dehydrocorybulbine
J115814
KW 4490
hCAII
Narcissin
UR12592
PARP1
XmAb 662
BPN14770
Photoinduced synthesis
SDZ NKT343
LUF7996
Wy
hotplate test
PF 5212371
SJPYT328
Taprizosin
mitochondrial enzyme
Antibiotic
Pla2g2d
Guattegaumerine
Hedgehog agonist1
TK2
Isopentenyl monophosphate disodium
L 165041
MK 966
PP 1466
EGFR
Dimethyl biphenyl
low cellular toxicity
Glimepiride
RANKL
IONIS
Comanthoside B
BNM
MCE
SQ15102
MOG 蛋白, Mouse (P.pastoris, His)
Sulfaproxyline
LY 294468
4′
ADC Antibody
MUM1 抗体 (YA2408)（MUM1 Antibody (YA2408)）
(1S,3R)
HEK 293T
L
Cytochrome C 抗体 (YA4145)（Cytochrome C Antibody (YA4145)）
CHMFL
GSK3179106
Nacresertib
XRCC4 抗体 (YA5361)（XRCC4 Antibody (YA5361)）
Apoptosis inducer23
TS 002902
RO 3244794
Plasma proteins
N1
PGC1
KNT
TG
Cd47
PROTAC Linker
Acetyl heptapeptide
NE
Margetuximab
MOR agonist 2
Z 21115
AC
Nrf2 抗体 (YA5510)（Nrf2 Antibody (YA5510)）
USP21 蛋白, Human (356a.a)
p18SMI
CCN2
Pkib
Delbonine
Olmesartan impurity 7
Olmesartan impurity 4
4
Olmesartan impurity 3
Bavituximab (Mouse IgG1)
CTS
Tetraketide
Olmesartan impurity 2 (N2
MMPSI (Standard)
Magnosalin
Indaconitine (15
Zocilurtatug (ZL
Chikusaikoside Ⅱ
Cirsiumaldehyde (Standard)
Drimiopsin D
Desmosteryl linoleate
Lehmbachol D
VBI
Vedastotug (BAT6026)
Machigline
Fiscalin B
Fusarielin A
Fiscalin A
Cimiracemoside D
Integracin A ((
Uvariol (21
(+)
Aspergillon A
Tuberostemonine A
Sinensin
Cinnamolide
Spirotryprostatin A
Neoschaftoside
Phomaligol A
Valancitug
Odoratisol B
Senkyunolide E (千叶内酯 E)
Flagranone B
Flagranone C
Phlorisovalerophenone
6
Flagranone A
Junipediol A
3
NQO2 Human Pre
Codlemone (Codlelure，十二碳二烯醇)
Ginsenoyne K
Olmesartan impurity 15
ADC Control Human IgG1
(+)
Olmesartan impurity 11
Olmesartan impurity 12
Heilaohuguosus A
Mucopolysaccharidosis type IIIB characterisation and expression of wild
Inhibitory effect of black tea pigments, theaflavin‑3/3'
Ugandenial A (乌干否认 A)
5,8
Malate Dehydrogenase, Porcine
Anti
JTV
(S,R,S)
Idi2
BMS 566394
RO
FABP3
CD98 抗体 (YA9142)（CD98 Antibody (YA9142)）
ATTO 590 azide
resting spores
EET analog
SRP 5051
Il7
Syrian Golden hamsters
LY
DLK2
Apom Rat Pre
CTU2 Human Pre
Uty
Wy27569
Erh
THPO
Nfyb Rat Pre
ADM 抗体 (YA7942)（ADM Antibody (YA7942)）
CDK12 Human Pre
25C
Bruceine J
Munc13
6
alkyne moiety
Chick cyanogen bromide digested peptide9
3''
(R,S)
SMARCA
A novel cytotoxic C
20
Boc
DMTr
CYP4A11/CYP4F2
G0/G1
6
Harnessing Fluorescent Moenomycin A Antibiotics for Bacterial Cell Wall Imaging Studies PMID 34606179
AZD5153 6
Isooxoflaccidin
PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes PMID 32004565
SCH 54292
BQR
HDAC8
Coumarin6
histamine H3R
ERB 2
MX 107
Dirlotapide
TIMP1
LDN0212320
PT 217
ZY19489
Anti
S 32212
Pantinin
JTX8064
signal pathway analysis
SHR
CDK9 degrader
Seneganolide 301530
PXS
DZIF
Ephb1
Lipid DIM
Cimigenol
Butafenacil
ABBV
Unlabeled FXX
Ac
Astilbin (Standard)
KBP
MEDI
Goat IgG Fc fragment
intra
RB
Flutoprazepam
TTNPB
SB
LY3041658
Anticancer Drug
AHR15010
LH 1513
KNI 272
N
L 902688
Btd
Ureidopropionic acid
BRL 46470
TAK
GlyH 101
Lsamp
BRD
YM
ZEN
hCBE 11
Goniothalenol
GGTI
Antibiotic202
A glutathione S
VU6024945
Ursodiol
SAR
Pavinetant (Standard)
Taltobulin intermediate
Levodopa (Standard)
Apoptosis inducer
PBG (Standard)
Il13
RP 101988
UBE2M 抗体 (YA7797)（UBE2M Antibody (YA7797)）
L 159282
U
G1 phase arrest
ZINC08792355
INBRX
CO
Hippo (MST)
Y 02224
DBCO
BI
L
NSF
LY
GNAS 抗体 (YA6582)（GNAS Antibody (YA6582)）
AE
LSN3318839
GDC
NCI
Ipratropium bromide
Solvent Green7
Dicloromezotiaz
ILV 094
Human IL5RA mRNA
Emfizatamab
thermosetting coating
AZD9592
Sulfaisodimidine
BBI 4000
Nesfrotamig
KT 611
共1190页
首页
上一页
1113
1112
1111
1110
1109
1108
1107
1106
1105
1104
1103
下一页
尾页
生物活性分子
ICP证:
粤ICP备2021105330号-3
联系人QQ：9145908
返回首页
RSS更新